Hybrid nanomaterial complexes for advanced phage-guided gene delivery

Molecular Therapy Nucleic Acids

Volumn 3, Issue , 2014, Pages e185-

  Yata, Teerapong ^a   Lee, Koon Yang ^b   Dharakul, Tararaj ^c   Songsivilai, Sirirurg ^c   Bismarck, Alexander ^b   Mintz, Paul J ^b   Hajitou, Amin ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

Bacteriophage; Biomaterials; Cancer; Cationic Polymers; Targeted Gene Transfer; Viral Particles

Indexed keywords

CD51 ANTIGEN; GANCICLOVIR; NANOCARRIER; POLYMER; THYMIDINE KINASE; HERPESVIRUS VECTOR; NANOMATERIAL; VIRUS ENZYME;

ANIMAL CELL; ARTICLE; BACTERIOPHAGE; CANCER CELL; CELL ADHESION; CELL DEATH; CELL KILLING; CELL STRUCTURE; CELL SURFACE; CELL TYPE; CELL VIABILITY; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYTOTOXICITY; ENDOSOME; EUKARYOTIC CELL; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENE VECTOR; GENETIC ENGINEERING; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTERNALIZATION; LYSOSOME; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; RGD4C PHAGE; SUICIDE GENE THERAPY; TRANSGENE; TUMOR SPHEROID; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE; ANIMAL TISSUE; BYSTANDER EFFECT; CYTOPLASM; DRUG EFFICACY; GLIOBLASTOMA; GLIOMA CELL; HYBRID; IN VITRO STUDY; NANOBIOTECHNOLOGY; VIRUS ATTACHMENT; VIRUS CAPSID;

EID: 84907342875     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2014.37     Document Type: Article

References (50)

1. Liu, G, Swierczewska, M, Lee, S and Chen, X (2010). Functional nanoparticles for molecular imaging guided gene delivery. Nano Today 5: 524-539.
2. Verma, IM and Weitzman, MD (2005). Gene therapy: twenty-frst century medicine. Annu Rev Biochem 74: 711-738.
3. Waehler, R, Russell, SJ and Curiel, DT (2007). Engineering targeted viral vectors for gene therapy. Nat Rev Genet 8: 573-587.
4. Wang, B, Yi, WJ, Zhang, J, Zhang, Q F, Xun, MM and Yu, XQ (2014). TACN-based cationic lipids with amino acid backbone and double tails: materials for non-viral gene delivery. Bioorg Med Chem Lett 24: 1771-1775.
5. Di Giovine, M, Salone, B, Martina, Y, Amati, V, Zambruno, G, Cundari, E et al. (2001). Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophage. Virology 282: 102-112.
6. Hart, SL, Knight, AM, Harbottle, R P, Mistry, A, Hunger, HD, Cutler, DF et al. (1994). Cell binding and internalization by flamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide. J Biol Chem 269: 12468-12474.
7. Ivanenkov, V, Felici, F and Menon, AG (1999). Uptake and intracellular fate of phage display vectors in mammalian cells. Biochim Biophys Acta 1448: 450-462.
8. Larocca, D, Witte, A, Johnson, W, Pierce, GF and Baird, A (1998). Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Hum Gene Ther 9: 2393-2399.
9. Piersanti, S, Cherubini, G, Martina, Y, Salone, B, Avitabile, D, Grosso, F et al. (2004). Mammalian cell transduction and internalization properties of lambda phages displaying the full-length adenoviral penton base or its central domain. J Mol Med (Berl) 82: 467-476.
10. Monaci, P, Urbanelli, L and Fontana, L (2001). Phage as gene delivery vectors. Curr Opin Mol Ther 3: 159-169.
11. Monk, AB, Rees, CD, Barrow, P, Hagens, S and Harper, DR (2010). Bacteriophage applications: where are we now? Lett Appl Microbiol 51: 363-369.
12. Lang, LH (2006). FDA approves use of bacteriophages to be added to meat and poultry products. Gastroenterology 131: 1370.
13. Greenstein, D and Brent, R (2001). Introduction to vectors derived from flamentous phages. Curr Protoc Mol Biol Chapter 1: Unit1.14.
14. Hajitou, A, Lev, DC, Hannay, JA, Korchin, B, Staquicini, FI, Soghomonyan, S et al. (2008). A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging. Proc Natl Acad Sci USA 105: 4471-4476.
15. Hajitou, A, Rangel, R, Trepel, M, Soghomonyan, S, Gelovani, JG, Alauddin, MM et al. (2007). Design and construction of targeted AAVP vectors for mammalian cell transduction. Nat Protoc 2: 523-531.
16. Hajitou, A, Trepel, M, Lilley, CE, Soghomonyan, S, Alauddin, MM, Marini, FC 3rd et al. (2006). A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell 125: 385-398.
17. Tandle, A, Hanna, E, Lorang, D, Hajitou, A, Moya, CA, Pasqualini, R et al. (2009). Tumor vasculature-targeted delivery of tumor necrosis factor-alpha. Cancer 115: 128-139.
18. Trepel, M, Stoneham, CA, Eleftherohorinou, H, Mazarakis, ND, Pasqualini, R, Arap, W et al. (2009). A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transfer. Mol Cancer Ther 8: 2383-2391.
19. Przystal, JM, Umukoro, E, Stoneham, CA, Yata, T, O'Neill, K, Syed, N et al. (2013). Proteasome inhibition in cancer is associated with enhanced tumor targeting by the adeno-associated virus/phage. Mol Oncol 7: 55-66.
20. Stoneham, CA, Hollinshead, M and Hajitou, A (2012). Clathrin-mediated endocytosis and subsequent endo-lysosomal traffcking of adeno-associated virus/phage. J Biol Chem 287: 35849-35859.
21. Hood, JD, Bednarski, M, Frausto, R, Guccione, S, Reisfeld, RA, Xiang, R et al. (2002). Tumor regression by targeted gene delivery to the neovasculature. Science 296: 2404-2407.
22. Kia, A, Przystal, JM, Nianiaris, N, Mazarakis, ND, Mintz, PJ and Hajitou, A (2012). Dual systemic tumor targeting with ligand-directed phage and Grp78 promoter induces tumor regression. Mol Cancer Ther 11: 2566-2577.
23. Nel, AE, Mädler, L, Velegol, D, Xia, T, Hoek, EM, Somasundaran, P et al. (2009). Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8: 543-557.
24. Akinc, A, Thomas, M, Klibanov, AM and Langer, R (2005). Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 7: 657-663.
25. Friedrich, J, Ebner, R and Kunz-Schughart, LA (2007). Experimental anti-tumor therapy in 3-D: spheroids-old hat or new challenge? Int J Radiat Biol 83: 849-871.
26. Kunz-Schughart, LA, Freyer, J P, Hofstaedter, F and Ebner, R (2004). The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen 9: 273-285.
27. Al-Abd, AM, Lee, SH, Kim, SH, Cha, JH, Park, TG, Lee, SJ et al. (2009). Penetration and effcacy of VEGF siRNA using polyelectrolyte complex micelles in a human solid tumor model in-vitro. J Control Release 137: 130-135.
28. Al-Jamal, W T, Al-Jamal, K T, Bomans, PH, Frederik, PM and Kostarelos, K (2008). Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer. Small 4: 1406-1415.
29. Petrenko, V, and Smith, G (2011). Phage Nanobiotechnology. RSC Publishing: Cambridge.
30. Shao, W, Paul, A, Abbasi, S, Chahal, PS, Mena, JA, Montes, J et al. (2012). A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for effcient siRNA delivery in breast cancer therapy: preparation and in vitro analysis. Int J Nanomedicine 7: 1575-1586.
31. Boeckle, S and Wagner, E (2006). Optimizing targeted gene delivery: chemical modifcation of viral vectors and synthesis of artifcial virus vector systems. AAPS J 8: E731-E742.
32. Kang, E and Yun, CO (2010). Current advances in adenovirus nanocomplexes: more specifcity and less immunogenicity. BMB Rep 43: 781-788.
33. Chilton, JM and Le Doux, JM (2008). Complexation of retroviruses with polymers signifcantly increases the number of genes transferred to murine embryonic stem cells, but does not raise transgene expression levels. Biotechnol Appl Biochem 51(Pt 3): 141-151.
34. Landazuri, N, Krishna, D, Gupta, M and Le Doux, JM (2007). Retrovirus-polymer complexes: study of the factors affecting the dose response of transduction. Biotechnol Prog 23: 480-487.
35. Moulay, G, Boutin, S, Masurier, C, Scherman, D and Kichler, A (2010). Polymers for improving the in vivo transduction effciency of AAV2 vectors. PLoS One 5: e15576.
36. Kim, YK, Choi, J Y, Jiang, HL, Arote, R, Jere, D, Cho, MH et al. (2009). Hybrid of baculovirus and galactosylated PEI for effcient gene carrier. Virology 387: 89-97.
37. Yang, Y, Lo, SL, Yang, J, Yang, J, Goh, SS, Wu, C et al. (2009). Polyethylenimine coating to produce serum-resistant baculoviral vectors for in vivo gene delivery. Biomaterials 30: 5767-5774.
38. Vinci, M, Gowan, S, Boxall, F, Patterson, L, Zimmermann, M, Court, W et al. (2012). Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol 10: 29.
39. Rejman, J, Oberle, V, Zuhorn, IS and Hoekstra, D (2004). Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 377(Pt 1): 159-169.
40. Hemminga, MA, Vos, WL, Nazarov, P V, Koehorst, RB, Wolfs, CJ, Spruijt, RB et al. (2010). Viruses: incredible nanomachines. New advances with flamentous phages. Eur Biophys J 39: 541-550.
41. Luo, D and Saltzman, WM (2000). Enhancement of transfection by physical concentration of DNA at the cell surface. Nat Biotechnol 18: 893-895.
42. Dobrzyńska, I, Szachowicz-Petelska, B, Sulkowski, S and Figaszewski, Z (2005). Changes in electric charge and phospholipids composition in human colorectal cancer cells. Mol Cell Biochem 276: 113-119.
43. Utsugi, T, Schroit, AJ, Connor, J, Bucana, CD and Fidler, IJ (1991). Elevated expression of phosphatidylserine in the outer membrane leafet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 51: 3062-3066.
44. Burdick, MD, Harris, A, Reid, CJ, Iwamura, T and Hollingsworth, MA (1997). Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines. J Biol Chem 272: 24198-24202.
45. Yoon, WH, Park, HD, Lim, K and Hwang, BD (1996). Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells. Biochem Biophys Res Commun 222: 694-699.
46. Rosenkranz, AA, Yachmenev, S V, Jans, DA, Serebryakova, NV, Murav'ev, VI, Peters, R et al. (1992). Receptor-mediated endocytosis and nuclear transport of a transfecting DNA construct. Exp Cell Res 199: 323-329.
47. Hashida, M, Takemura, S, Nishikawa, M and Takakura, Y (1998). Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine). J Control Release 53: 301-310.
48. Nishikawa, M, Takemura, S, Takakura, Y and Hashida, M (1998). Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties. J Pharmacol Exp Ther 287: 408-415.
49. Wagner, E, Plank, C, Zatloukal, K, Cotten, M and Birnstiel, ML (1992). Infuenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA 89: 7934-7938.
50. Suh, W, Chung, JK, Park, SH and Kim, SW (2001). Anti-JL1 antibody-conjugated poly (L-lysine) for targeted gene delivery to leukemia T cells. J Control Release 72: 171-178.